Assessment
mepolizumab
Add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (EGPA)
- Modules
- IQWiG assessments · G-BA decisions
- Connections
- 2
Connected evidence
2 relations